Related Experiment Video
Updated: Jul 18, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Pharmacogenetics of asthma
1Division of Therapeutics and Molecular Medicine, University Hospital of Nottingham, Nottingham NG7 2UH, UK. Ian.Hall@nottingham.ac.uk
Chest
|December 15, 2006
Summary
Pharmacogenetics uses genetic information to tailor asthma treatments for better efficacy and fewer side effects. While not yet standard, this personalized medicine approach holds promise for future asthma management.
Area of Science:
- Pharmacogenetics
- Pulmonology
- Personalized Medicine
Background:
- Pharmacogenetics enables personalized medicine by leveraging genetic data to optimize drug efficacy and minimize adverse effects.
- Current clinical applications of pharmacogenetics are expanding, yet its use in asthma management remains largely developmental.
Purpose of the Study:
- To explore potential pharmacogenetic strategies for improving asthma treatment.
- To discuss the current status and future prospects of pharmacogenetics in asthma care.
Main Methods:
- Review of existing literature on pharmacogenetics and asthma.
- Discussion of potential pharmacogenetic targets and biomarkers for asthma.
- Analysis of clinical implications for personalized asthma management.
Main Results:
- Several pharmacogenetic approaches show potential for enhancing asthma therapy.
- Genetic variations can influence individual responses to asthma medications.
- Further research is needed to translate these findings into routine clinical practice.
Conclusions:
- Pharmacogenetics presents a promising avenue for optimizing individual asthma treatment plans.
- The integration of pharmacogenetics into routine asthma care is an evolving field.
- Personalized approaches guided by genetic insights could significantly advance asthma management.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...